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a b s t r a c t
Recreating some of the emergent behavior seen in biological reaction networks is an important goal in
the new ﬁeld of systems chemistry. One of the classic examples of complex behavior is bistability, which
is abundantly used in living organisms for switching between cellular states. Here, we create a bistable
switch based on the autocatalytic activation and inhibition of the enzyme trypsin under ﬂow conditions.
We investigate the inﬂuence of the inhibitor structure, and hence inhibition kinetics, on the properties of
the bistable switch.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
All-or-none responses are crucial in cellular processes such as
differentiation,1 cell motility,2 apoptosis,3 and cell cycle control.4,5
This type of response is typically regulated by bistable switch-
es,6e8 that are able to maintain a stable state A until a trigger
switches the system to state B, after which this new state persists
even when the trigger is removed, a property called hysteresis. In
the past decades, artiﬁcial networks have been developed that
display bistability, including ones based on DNA circuits,9 en-
zymes,10 inorganic chemistry,11 and most recently, small organic
molecules.12 In addition, mathematical analyses have indicated that
many network motifs can lead to bistability as long as they contain
a sufﬁcient degree of nonlinear kinetics.13,14 We propose to use a
basic motif, displayed in Fig. 1A, where an autocatalytic, positive
feedback loop in which trypsin (Tr) catalyzes its own formation
from its precursor trypsinogen (Tg), is combined with a trypsin
inhibitor (Inh). Importantly, trypsinogen displays self-activation
due to residual tryptic activity, which ensures a slow, but contin-
uous production of trypsin.15 This motif is comparable with the one
that was described recently, in which thiols were constantly pro-
duced through thioester hydrolysis, ampliﬁed through native
chemical ligation, and inhibited by maleimides.12 Importantly,
bistability is only obtained under out-of-equilibrium conditions in
these systems, and to that end we implement a ﬂow reactor.
In this report, we achieve bistability by combining kinetic
studies with batch experiments and computational modelling to
predict the conditions necessary for bistability in a ﬂow reactor.
Previously, we developed this strategy to design a trypsin oscillator
based on a different network motif than the one used here.16
Furthermore, we now synthesize a new, more potent inhibitor of
trypsin by modifying a commercially available trypsin inhibitor,
and probed the inﬂuence of the inhibition kinetics on the proper-
ties of the bistable system. As we saw before in the trypsin oscil-
lator,17 small modiﬁcations in molecular structure can have a
profound inﬂuence on the behavior of complex, out-of-equilibrium
networks.
2. Results and discussion
In a reactor, the autocatalytic formation of trypsin is antago-
nized by the outﬂowof reaction products.18 Intuitively, at extremely
high ﬂow rates, the outﬂow of the reactor is similar to its inﬂow,
because trypsinogen is washed out of the reactor before it can be
activated. Conversely, one imagines that under batch conditions
(no ﬂow) the reaction will proceed until all trypsinogen has been
converted into trypsin and thermodynamic equilibrium is reached.
Under all circumstances, the addition of inhibitor counteracts the
autocatalysis. In a bistable system, a regime exists in which the
starting concentration of trypsin determines the ﬁnal state of the
system. At low concentrations of trypsin, outﬂow and inhibition
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outcompete autocatalysis, but at higher concentrations of trypsin,
the rate of autocatalysis is increased tremendously due to its
nonlinear nature, and a high concentration of trypsin is maintained.
Therefore, it is necessary for the inhibitor to strongly oppose
trypsin formation (i.e. relatively high rate of inhibition), while
allowing the trypsin concentration to quickly increase when
autocatalysis outcompetes inhibition (for instance when all inhib-
itor has reacted). These are the properties we are looking for below,
when we test two different trypsin inhibitors.
2.1. Synthesis and kinetic studies of potent inhibitor
First, we synthesized an arginine-like analogue of the commer-
cially available trypsin inhibitor 4-(2-aminoethyl)benzenesulfonyl
ﬂuoride (AEBSF, compound1 in Fig.1b)byguanylating its amineusing
a standard two-step procedure (Fig. 1A).19 In the ﬁrst step, AEBSF re-
acts with N,N’-di-boc-thiourea (2) to form a boc-protected guanidi-
nium group (compound 3), after which a simple boc-deprotection
step yields the desired compound 4-(2-guanidinoethyl)benzene-
sulfonyl ﬂuoride (GEBSF, 4).
Next, we investigated the inhibitory properties bymixing GEBSF
(40 mM) with trypsin (29.4 mM). The activity of trypsin was
measured over time by a ﬂuorogenic assay (see the Experimental
section). Fig. 1C shows that trypsin is fully inhibited after 15 min
(orange dots), indicating that GEBSF is indeed a potent inhibitor of
trypsin. The experimental datawere ﬁtted to a bimolecular reaction
model in COPASI (Fig. 1C, orange dashed lines), and a parameter
estimation procedure resulted in a rate constant kinh,GEBSF of
1104 mM1 h1. This value is much higher than the trypsin inhi-
bition rate constant for AEBSF (53 mM1 h1) we measured before,
but also considerably larger than the kcat/KM value (a measure of
enzymatic efﬁciency) of trypsinogen conversion by trypsin
(63 mM1 h1).16 Therefore, it is expected that GEBSF would be
more suitable to antagonize autocatalytic trypsin production than
AEBSF.
Hydrolysis of the sulfonyl ﬂuoride moiety is a side reaction that
needs to be measured as well, as it results in a sulfonic acid that
inhibits trypsin only weakly and reversibly. To that end, GEBSF was
dissolved in deuterated buffer, and changes in the benzene ring
peaks due to hydrolysis were monitored by 1H NMR at 22 C. The
reaction was considered to be pseudo-ﬁrst order, and a linear ﬁt
through experimental data points expressed as ln([GEBSF]/
[GEBSF]0) yielded a hydrolysis rate constant khyd,GEBSF of 0.044
h1 (t½ ¼ 15.8 h, Fig. 1D). This value is comparable with the hy-
drolysis rate constant for AEBSF (0.034 h1),16 andwill be taken into
account in all computational models mentioned below. The weak,
reversible inhibition of trypsin by the hydrolyzed inhibitor is not
considered in the models, as initial calculations showed no signif-
icant effect thereof on the behavior of the network.
2.2. Batch experiments and modelling
Next, we tested the properties of the inhibitors in batch exper-
iments in which thermodynamic equilibrium is inevitably reached.
Trypsinogen (100 mM) is fully converted into trypsin within two
hours in the absence of inhibitor, and the S-shaped activation curve
is characteristic for autocatalytic reactions (orange dots in Fig. 2).
The activation of trypsinogen is severely delayed in the presence of
AEBSF (50e100 mM), and the S-shaped curve is much more gradual
than in the absence of inhibitor (top panel in Fig. 2). The experi-
ment with 100 mMAEBSF still yields a ﬁnal trypsin concentration of
about 40 mM due to signiﬁcant hydrolysis of the inhibitor at this
timescale. In contrast, lower concentrations (5e9 mM) of GEBSF are
required to obtain a similar delay in activation as with high con-
centrations of AEBSF, because of the higher inhibition rate constant
of GEBSF. Consequently, higher ﬁnal concentrations of trypsin are
obtained when GEBSF is used (bottom panel in Fig. 2). Moreover, in
case of GEBSF the steepness of the activation curves strongly re-
sembles the one in the absence of inhibitor.
Then, we built a model describing these batch experiments in
COPASI to gain more insight in the differences between the in-
hibitors. In the model, four reactions are considered: 1) autoacti-
vation of trypsinogen, 2) activation of trypsinogen by trypsin, 3)
inhibition of trypsin by an inhibitor, 4) hydrolysis of the inhibitor. A
Fig. 1. A) The enzymatic reaction network used to obtain bistability. Trypsin is autocatalytically produced from trypsinogen, but deactivated by an inhibitor. B) Modiﬁcation of the
trypsin inhibitor AEBSF by guanylation of its amine. Details of the synthesis are in the Experimental Section. C) Inhibition of trypsin ([Tr]0 ¼ 29.4 mM) by GEBSF ([GEBSF]0 ¼ 40 mM)
in 0.1 M Tris-HCl, pH 7.7, 20 mM CaCl2 at 22 C. The experimental data (dots) were ﬁtted by a bimolecular reaction model in COPASI (dashed line). D) Hydrolysis of the sulfonyl
ﬂuoride of GEBSF as followed by 1H NMR in 50 mM Tris-HCl, pD 7.7, in D2O containing 20 mM CaCl2 at 22 C. The experimental data (dots) were ﬁtted in Origin (solid line).
Abbreviations: Tg ¼ trypsinogen, Tr ¼ trypsin, Inh ¼ inhibitor, AEBSF ¼ 4-(2-aminoethyl)benzenesulfonyl ﬂuoride, GEBSF ¼ 4-(2-guanidinoethyl)benzenesulfonyl ﬂuoride.
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genetic algorithm was employed to estimate the rate constant for
autoactivation of trypsinogen, which resulted in a value of
2.3*103 mM1 h1. Gratifyingly, the model ﬁts (dashed lines in
Fig. 2) were in excellent agreement with experimental data.
Parameter estimation resulted in inhibition rate constants of
86 mM1 h1 for AEBSF and 1217 mM1 h1 for GEBSF, which is
close to the values obtained by isolated inhibition studies.
Thereafter, we deﬁned three different regions in the batch ex-
periments: I) a delay region during which [Tr] < 1 mM, and inhi-
bition is stronger than autocatalysis, II) a competition region, in
which inhibition and autocatalysis compete, and III) a low [Inh]
regime, in which most of the inhibitor has already reacted
([Inh] < 0.1 mM). Two batch experiments were simulated, one with
AEBSF (84 mM) and one with GEBSF (6.95 mM), that both showed a
delay time of 6 h (Fig. 3A). Again, we see that the use of GEBSF
results in a steeper rise in trypsin concentration, but now we can
also observe that the duration of the competition region is strongly
dependent on the inhibition rate constant. In case of GEBSF the
competition region is short, as only 2.6 mM of inhibitor is left at the
end of the delay region, which is quickly consumed by the auto-
catalytically formed trypsin. Consequently, at end of the competi-
tion region there is still a high concentration of trypsinogen
(81 mM), explaining the switch-like behavior. In contrast, the
competition region in case of AEBSF is long, as there is still 59 mMof
inhibitor present at the start of the competition region, and it ends
when trypsinogen is already fully activated. Therefore, the steep-
ness of the trypsin curve is greatly reduced in the latter case, as
autocatalysis has to compete with inhibition. Importantly, the
concentration of trypsinogen (green lines in Fig. 3A) is similar at the
start of the competition region for both AEBSF ([Tg] ¼ 93 mM) and
GEBSF ([Tg] ¼ 96 mM), and the differences in steepness of the
trypsin curves cannot be attributed to a substrate-depletion effect
(i.e. that most of the trypsinogen was already converted in the low
[Tr] region).
Additional computational analyses showed that the delay time
is very sensitive to initial [GEBSF] (orange line in Fig. 3B), while the
switch-like behavior e expressed as maximal steepness of the [Tr]
curve, or (d[Tr]/dt)max e is retained over a wide range of delay
times (orange line in Fig. 3C). In contrast, the delay time increases
gradually with increasing [AEBSF] (cyan line in Fig. 3B), and the
maximal steepness drops considerably over a small range of delay
times (1e4 h, cyan line in Fig. 3C). These results indicate that GEBSF
is a better candidate to obtain bistability under ﬂow conditions
than AEBSF, because the former has a greater ability to delay the
onset of autocatalytic growth whilst still exhibiting switch-like
behavior.
2.3. Bistability in ﬂow experiments
Finally, we searched for bistability under ﬂow conditions. We
used a 250 mL continuously-stirred tank reactor (CSTR),16 that was
fed by three syringes loaded with either trypsinogen, inhibitor, or a
buffer solution (see Experimental Section 4.6 for details). In the
syringes, trypsinogen and the inhibitor were kept in acidic solu-
tions to prevent autoactivation and hydrolysis, respectively.
First, however, it is imperative to use a computational model to
estimate which inhibitor(s) and conditions are necessary to obtain
bistability. Themodel made inMATLAB contains the same reactions
as the COPASI model used to describe the batch experiments, but
the former also takes ﬂow into account. Note that ﬂow is hereafter
described by space velocity (SV, with units of h1), which is the
ratio of the ﬂow rate (in mL h1) over the reactor volume (in our case
Fig. 2. Batch experiments in which trypsinogen ([Tg]0 ¼ 100 mM) was mixed with
various concentrations of AEBSF (top panel) or GEBSF (bottom panel) 0.1 M Tris-HCl,
pH 7.7, 20 mM CaCl2 at 22 C. The experimental data points (dots) were ﬁtted with
a genetic algorithm in COPASI (dashed lines).
Fig. 3. Modelling batch experiments in COPASI. A) Simulation of trypsinogen ([Tg]0 ¼ 100 mM) mixed with either AEBSF (84 mM, top panel) or GEBSF (6.95 mM, bottom panel). Three
regions are distinguished: I) Low [Tr] (in red), II) Competition between inhibition and autocatalysis (in green), III) Low [Inh] (in blue. B) A plot of the delay time (duration of region I
in Figure 3A) vs the inhibitor concentration. C) A plot of the maximal steepness of the trypsin curve ((d[Tr]/dt)max in mM1 h1) vs the delay time. Abbreviations: Tg ¼ trypsinogen,
Tr ¼ trypsin, Inh ¼ inhibitor, AEBSF ¼ 4-(2-aminoethyl)benzenesulfonyl ﬂuoride, GEBSF ¼ 4-(2-guanidinoethyl)benzenesulfonyl ﬂuoride.
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250 mL). In the MATLAB model, the space velocity is ﬁrst increased
from 0 (i.e. batch conditions) to 4 h1 in small steps. The model
waits for 250 simulated hours before changing the space velocity to
obtain a ﬁnal steady state of the system, and uses the ﬁnal con-
centrations of compounds in the reactor as the initial conditions at
the next space velocity while keeping the inﬂow concentrations of
trypsinogen and inhibitor constant. After reaching a space velocity
of 4 h1, the concentrations in the reactor are set to zero again, and
the process is repeated, but now for decreasing space velocity. The
system is considered bistable when a difference is observed be-
tween the ﬁnal trypsin concentration obtained at increasing space
velocity as compared to the reverse process. Ultimately, the dif-
ferences in trypsin concentration (D[Tr] in mM) are plotted in a
phase diagram of initial inhibitor concentration vs the space
velocity.
Using this model, we did not ﬁnd bistability in the case of AEBSF,
but did observe a large bistable regime for GEBSF (Fig. 4A,
[Tg]0 ¼ 100 mM) as expected based on the results of the batch ex-
periments. Finally, we tested the model predictions in ﬂow exper-
iments using the CSTR. We indeed observed bistability and
hysteresis in trypsin concentration when the space velocity was
ﬁrst increased, and then decreased again (Fig. 4B). In addition, we
observed the same behavior at a constant space velocity, but at
changing concentrations of GEBSF (Fig. 4C). The states of high [Tr]
are named the thermodynamic branches in Fig. 4B and C, as they
resemble the ﬁnal high [Tr] reached at thermodynamic equilib-
rium. In contrast, the states of low [Tr] are called ﬂow branch and
inhibitor branch in Fig. 4B and C, respectively, since here the an-
tagonists of autocatalysis are dominant. In both ﬂow experiments,
we had to wait until at least six reactor volumes of ﬂuid had passed
through the reactor for the trypsin concentration to stabilize (the
steady-state concentrations of trypsin are plotted in Fig. 4B and C).
Additionally, we see that the steady state trypsin concentration is
lowered in the thermodynamic branch as the inhibition strength is
increased, either by increasing the space velocity or the [GEBSF].
The experimental results are in good agreement with the compu-
tational model, although the experimental bistable regime seems
to be slightly smaller than the computed one.
3. Conclusion
In this report, we have shown that a combination of synthesis,
kinetic studies, batch experiments, and computational modelling
resulted in the observation of bistability in a CSTR. Interestingly, we
observe that a small change in molecular structure can be crucial
for obtaining complex behavior, something we established in
previous work as well.16,17 Our work does not only expand the
available toolbox of complex networks, but we also foresee that our
bistable system can be implemented in enzyme-responsive, smart
materials.20e23 Furthermore, we expect that strong, natural trypsin
inhibitors such as soybean trypsin inhibitor and aprotinin (both are
proteins) can also be used to create trypsin-based bistable switches.
These alternative inhibitors are interesting for applications where
long reaction times may be required, such as in enzyme-responsive
materials, as these proteins do not hydrolyze in contrast to the
inhibitors used in this study.
4. Experimental section
4.1. Synthesis of 4-(2-N,N’-diboc-guanidinoethyl)benzenesulfonyl
ﬂuoride (compound 3)
N,N0-Di-Boc-thiourea (31.6 mg, 114.7 mmol, 1.2 eq) and 4-(2-
aminoethyl)benzenesulfonyl ﬂuoride hydrochloride (AEBSF,
22.9 mg, 95.6 mmol, 1 eq) were ﬁrst dried under vacuum, and af-
terwards suspended in dry DCM. Dry N,N’-diisopropylethylamine
(66 mL, 382 mmol, 4 eq) and ﬁne powdered copper chloride dihy-
drate (19.6 mg, 114.7 mmol, 1.2 eq) were added in quick succession.
The mixture was stirred under nitrogen for one hour, and then
poured in 10% (w/v) KHSO4 solution. Next, ethyl acetate was added
and the organic phase was separated in a separatory funnel, and
subsequently washedwith KHSO4 and brine. Then, themixturewas
dried over Na2SO4, and the solvent was evaporated under reduced
pressure. The crude product was puriﬁed by silica column chro-
matography (ethyl acetate/heptane, 1:4, v/v) yielding the desired
compound 3 (17.1 mg, 38.2 mmol, 40%).
1H NMR: (400 MHz, CD3OD) d 8.14 (d, J ¼ 8.2 Hz, 2H), 7.71 (d,
J ¼ 8.3 Hz, 2H), 3.62 (t, J ¼ 7.1 Hz, 2H), 3.14 (t, J ¼ 7.0 Hz, 2H), 1.41 (s,
9H), 1.29 (s, 9H); LCQMS-ESI (Da): m/z observed 446.38 for
C19H29FN3O6Sþ [MþHþ]; m/z calculated for [MþHþ]: 446.18.
4.2. Synthesis of 4-(2-guanidinoethyl)benzenesulfonyl ﬂuoride
(GEBSF, compound 4)
Compound 3 (17.1 mg, 38.2 mmol) was dissolved in 1 mL
dioxane, and 1mL of 4MHCl in dioxanewas added, after which the
mixture was stirred overnight at room temperature. Then, the
mixture was concentrated under reduced pressure and diethyl
ether was added. The formed precipitate was centrifuged, washed
two times with diethyl ether, and dried under vacuum yielding the
desired compound 4 (GEBSF, 9.7 mg, 34.3 mmol, yield 90%).
1H NMR: (400 MHz, CD3OD) d 8.00 (d, J ¼ 8.2 Hz, 2H), 7.61 (d,
Fig. 4. A) Phase diagram of [GEBSF] vs space velocity obtained by simulations in MATLAB. B) Bistability in a ﬂow experiment ([Tg]0 ¼ 100 mM, [GEBSF]0 ¼ 8 mM) achieved by
changing space velocity once a stable trypsin concentration was reached. C) Bistability in a ﬂow experiment ([Tg]0 ¼ 100 mM, SV¼ 1 h1) achieved by changing [GEBSF] once a stable
trypsin concentration was reached. Error bars in B and C are standard deviations of [Tr] determinations at three different time points, after [Tr] had reached a steady state.
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J ¼ 8.1 Hz, 2H), 3.51 (t, J ¼ 7.0 Hz, 2H), 3.02 (t, J ¼ 7.0 Hz, 2H);
13C NMR: (125 MHz, CD3OD) d 147.4, 131.3, 131.1, 130.3, 128.4, 41.4,
34.5; LCQMS-ESI (Da): m/z observed 246.28 for C9H13FN3O2Sþ
[MþHþ]; m/z calculated for [MþHþ]: 246.07.
4.3. Inhibition of trypsin by GEBSF
Trypsin (29.4 mM)wasmixedwithGEBSF (40 mM) in 100mMTris-
HCl, pH 7.7, containing 20 mM CaCl2, and kept at 22 C. At multiple
time points, 20 mL of the reactionmixture was quenched with 180 mL
of a 0.1MKHSO4 solution.10mL of thequenched reactionmixturewas
added to 2.5 mL 50 mM Tris-HCl buffer, pH 7.7, containing 5 mg/mL
bis-(Z-Ile-Pro-Arg)-rhodamine 110, a ﬂuorogenic trypsin substrate.
Increase in ﬂuorescence intensity (lex¼ 470 nm, lem ¼ 520 nm) was
measured for 20 s, and its slope compared to a calibration curve to
calculate the concentration of active trypsin.
4.4. Hydrolysis of GEBSF
GEBSF (0.19 mg, 0.67 mmol, 1.03 mM starting concentration) was
dissolved in 650 mL 50 mM Tris-HCl, pD 7.7, in D2O containing
20 mM CaCl2, and hydrolysis was followed by 1H NMR (400 MHz).
The formation of hydrolyzed inhibitor was followed in time by
integrating the peaks of the phenyl ring, from which the [GEBSF]
over time was calculated.
4.5. Batch experiments
In the batch experiments in Fig. 2, 100 mM of trypsinogen was
mixed with varying concentrations of either AEBSF or GEBSF in
100mMTris-HCl, pH 7.7, containing 20mMCaCl2, and kept at 22 C.
The rest of the procedure was identical as described in section 4.3.
4.6. Flow experiments
Details on the fabrication of the CSTR and the experimental
setup can be found in our previous work.16 Three syringes were
connected to the reactor, which typically contained: I) trypsinogen
(272 mM, 2.40 mg/mL) in 4 mM HCl containing 40 mM CaCl2, II)
GEBSF (32 mM in 2 mM HCl), III) 0.5 M Tris-HCl, pH 7.7 buffer. The
ﬂow rate for trypsinogen was always half the total ﬂow rate
(effective starting concentration [Tg] ¼ 100 mM; note that in the
batch used for ﬂow experiments only 74% of trypsinogen was
active), and the ﬂow rates of inhibitor and buffer were changed in
case different concentrations of inhibitor had to be achieved (in all
cases, buffer capacity was at least 50 mM). Droplets from the outlet
tubing were collected using a BioRad 2110 fraction collector, in
which eppendorf tubes were placed containing 780 mL 0.1 M
KHSO4. The quenched solutions were analyzedwith the ﬂuorogenic
assay described in section 4.3. Droplet volume was determined by
measuring the time interval between falling droplets and multi-
plying this time with the ﬂow rate.
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